Table 2.
Analysis of demographic characteristics and bladder outcomes of women undergoing pelvic floor reconstructive surgery, stratified by reconstructive vs obliterative procedures and presence of mid-urethral sling procedures (n = 992)
| All POP procedures | Obliterative procedures | Reconstructive procedures | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | With MUS N (%) |
Without MUS N (%) |
p value | Total | With MUS N (%) |
Without MUS N (%) |
p value | Total | With MUS N (%) |
Without MUS N (%) |
p value | ||
| Total | 992 | 235 (23.7%, 21.1–26.4%) | 757 (76.3%, 73.6–78.9%) | 51 |
4 (7.8%, 2.9–19.5%) |
47 (92.2%, 80.5–97.1%) | 0.006 | 941 | 231 (24.5%, 21.9–27.4%) | 710 (75.5%, 72.6–78.1%) | p = 0.006 | ||
| Age (years) |
Mean (95%CI) |
61.5 (60.7–62.3) |
57.9 (56.3–59.5) |
62.6 (61.8–63.5) |
0.134 |
79.7 (77.9–81.4) |
77.5 (73.3–81.7) |
79.9 (78.0–81.8) |
0.969 |
60.5 (59.8–61.3) |
57.6 (56.0–59.2) |
61.5 (60.6–62.4) |
0.218 |
| Median (IQR) |
62 (53–71) |
57 (48–68) |
64 (55–72) |
80 (76–83) |
77 (75.5–79.5) |
80 (76–84) |
62 (53–69) |
57 (48–67) |
63 (54–70) |
||||
| Length of stay (days) |
Mean (95%CI) |
2.0 (1.3–2.7) |
1.8 (1.6–2.0) |
2.1 (1.1–3.0) |
0.078 | 1.6 (1.3–2.0) |
2.0 (0.0–4.3) |
1.6 (1.2–1.9) |
0.208 |
2.0 (1.3–2.8) |
1.8 (1.6–2.0) |
2.1 (1.1–3.1) |
0.077 |
| Median (IQR) |
1 (1–2) |
2 (1–2) |
1 (1–2) |
1 (1–2) |
1.5 (1–3) |
1 (1–2) |
1 (1–2) |
2 (1–2) |
1 (1–2) |
||||
| Number of voids to pass bladder protocol |
Mean (95%CI) |
3.0 (2.9–3.2) |
3.5 (3.1–4.0) |
2.9 (2.7–3.1) |
0.144 |
2.7 (2.2–3.2) |
3.3 (0.0–7.2) |
2.7 (2.2–3.1) |
0.409 |
3.0 (2.9–3.2) |
3.5 (3.0–4.0) |
2.9 (2.7–3.1) |
0.131 |
| Median (IQR) |
2 (2–3) |
2 (2–4) |
2 (2–3) |
2 (2–3) |
2 (2–4.5) |
2 (2–3) |
2 (2–3) |
2 (2–4) |
2 (2–3) |
||||
| Patients who went home with a catheter | N | 249 | 88 | 161 | p < 0.0001 | 9 | 0 | 9 | 0.335 | 240 | 88 | 152 | p < 0.0001 |
|
Proportion (95%CI) |
25.1% (22.5–27.9%) | 37.4% (31.5–43.8%) | 21.3% (18.5–24.4%) | 17.6% (9.3–30.9%) | - | 19.1% (10.1–33.3%) | 25.5% (22.8–28.4%) | 38.1% (32.1–44.5%) | 21.4% (18.6–24.6%) | ||||
| Elevated PVR after second void | N | 507 | 154 | 353 | < 0.0001 | 24 | 1 | 23 | 0.357 | 484 | 153 | 331 | 0.0001 |
| Proportion (95%CI) | 51.2% (48.0–54.3%) | 65.5% (59.2–71.3%) | 46.7% (43.2–50.3%) |
47.1% (33.6–61.0%) |
25% (0.08–92.9%) |
48.9% (34.8–63.3%) |
51.4% (48.2–55.7%) | 66.2% (59.7–72.3%) | 46.6% (42.9–50.4%) | ||||
| Crude Odds Ratio (95%CI) | - | 2.2 (1.6–2.9) | Reference | < 0.0001 | - | 0.3 (0.03–3.6) | Reference | 0.375 | - | 2.25 (1.65–3.06) | Reference | < 0.0001 | |
| Elevated PVR after third void | N | 404 | 132 | 272 | < 0.0001 | 17 | 1 | 16 | 0.713 | 388 | 131 | 257 | < 0.0001 |
| Proportion (95%CI) | 40.8% (37.7–43.9%) |
56.2 (49.8–62.4%) |
36.0% (32.6–39.5%) | 4.2% (2.6–6.7%) |
25% (0.08–92.9%) |
34.0% (21.7–49.0%) |
95.8% (93.3–97.4%) |
56.7% (50.1–63.2%) | 36.2% (32.7 – 39.9%)) | ||||
| Crude Odds Ratio (95%CI) | - | 2.3 (1.8–3.1) | Reference | < 0.0001 | - | 0.6 (0.06–6.7) | Reference | 0.714 | 2.3 (1.7–3.1) | Reference | < 0.0001 | ||
*p value s reflect chi-square tests to determine if differences between those with and without MUS procedures are significant at the p < 0.05 level